Iradimed (IRMD) Preferred Shares (2013 - 2014)
Iradimed's (IRMD) quarterly Preferred Shares came in at $140.0 in Q2 2014, little changed quarter-over-quarter from $140.0 in Q4 2013.
Powered by 
Analysis
Iradimed (IRMD) Preferred Shares (2013 - 2014) Analysis & Trends
Iradimed (IRMD) has reported Preferred Shares for 2 consecutive years, with $140.0 the latest figure, recorded in Q2 2014.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $140.0 in Q2 2014; TTM through Jun 2014 was $140.0, a N/A change from a year earlier, with the FY2013 full-year figure at $140.0, changed N/A from the prior year.
- Preferred Shares was $140.0 for Q2 2014 at Iradimed, roughly flat from $140.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $140.0 in Q4 2013 and troughed at $140.0 in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | - |